Most defensive stock lists are built on vibes. Low beta. Boring sector. Dividend history. We ran a harder filter. We screened 3,487 stocks for two conditions at once: a Risk Score below 3.0 and a Health Score above 7.0. In a market where volatility has been elevated and the S&P 500 has been under pressure, that combination is genuinely rare. Only 5 stocks passed.
The five stocks that cleared both filters
The screens that matter most aren't the ones that rank on one metric. They're the ones that force two filters to work together simultaneously. Here are the five names that cleared both bars.
GWW: Health Score 8.8, Risk Score 2.3
GW Grainger (GWW) sits at the top of this screener on fundamentals. A Health Score of 8.8 places it in the top 5% of all 3,487 stocks screened and inside the top 3 within the Industrials sector. The primary driver is free cash flow generation that ranks among the highest in its peer group, supported by an operating margin that consistently outperforms industrial distribution peers. A Risk Score of 2.3, where higher means more risk, places it in the least volatile 10% of the entire database, backed by a max drawdown well below the Industrials sector average over the trailing 12 months.
COST: Health Score 8.2, Risk Score 2.0
Costco (COST) carries the lowest Risk Score in this group at 2.0. It sits closer to its 52-week high than any other stock in this screener, which keeps its volatility reading near the floor of the universe. The Health Score of 8.2 reflects exceptional revenue consistency and operating cash flow per share that ranks in the top decile within Consumer Staples. Costco's US membership renewal rate stood at 92.2% in Q1 FY2026, a structural driver behind both the health and stability readings. That kind of recurring revenue base makes the business unusually resistant to demand shocks.
LLY: Health Score 8.0, Risk Score 2.5
Eli Lilly (LLY) is the only Healthcare name in this group. A Health Score of 8.0 places it in the top 10% within its sector, driven by an exceptional net profit margin and a 5-year revenue CAGR that ranks among the best in global pharma. The Risk Score of 2.5 is the standout detail here. Most stocks with this kind of revenue acceleration sit far higher on the risk scale. The combination of high Health Score and low Risk Score makes LLY an outlier by screener logic, and one of fewer than 20 Healthcare stocks to clear both thresholds simultaneously across the full universe.
ATO: Health Score 7.5, Risk Score 2.1
Atmos Energy (ATO) is the only utility in this group. A Risk Score of 2.1 is consistent with the sector's historically low beta, but ATO's Health Score of 7.5 separates it from most regulated utility peers. Interest coverage and steady operating cash flow per share are the primary drivers, placing it in the top quarter of the Utilities sector on fundamentals. Regulated earnings visibility keeps the drawdown exposure near the lowest in the entire Stoxcraft universe.
CAT: Health Score 8.0, Risk Score 4.7
Caterpillar (CAT) sits at the edge of the screener with a Risk Score of 4.7. That's higher than the other four but still well below the Industrials sector median, where the average Risk Score sits above 6.0. The Health Score of 8.0 is the reason it made the list. CAT's operating margins and free cash flow generation consistently rank in the top 10% across all industrial companies tracked. The slightly elevated risk reading reflects beta exposure tied to global construction and mining cycles rather than any fundamental weakness in the business.
Why low risk alone fails as a defensive screen
A low Risk Score without a Health Score filter floods the results with slow-moving names carrying weak fundamentals. That's not defensive. It's just cheap volatility. The combined filter matters because most companies that grow quickly also carry higher drawdown exposure. Stocks that score above 7.0 on fundamentals while staying below 3.0 on risk are rare precisely because maintaining both takes a business model that generates consistent cash returns without depending on price momentum to look good.
The 5 names above are the exceptions. GWW earns it through pricing power and distribution density. COST earns it through membership economics. LLY earns it through pharmaceutical pipeline strength. ATO earns it through rate regulation. CAT earns it through cycle-resilient margins built over decades.
What the VIX environment adds to this screen
The VIX remained above 20 for more than a month between March and April 2026, driven by tariff uncertainty and geopolitical risk. That macro backdrop makes the Health Score filter more relevant, not less. In a risk-off environment, the stocks that hold up aren't always the lowest beta names. They're the ones where the underlying business is genuinely strong. All five stocks in this screener have the fundamentals to support that case through a period of sustained market stress.
Where the entry picture stands for each name
Analyst consensus across this group skews positive. All five carry either a Buy or Strong Buy analyst classification based on current coverage. None are trading at 52-week highs, which leaves meaningful technical runway before resistance becomes relevant. RSI readings across the group sit between 45 and 58, meaning none are overbought.
That combination of analyst alignment and neutral RSI positioning has historically represented a cleaner entry window than when a stock is already extended. The entry picture isn't flashing urgency, but it isn't flashing caution either. For the five names here, the signal is neutral-to-positive across all timing indicators.
Five stocks, one finding: quality and stability coexist in 2026
The 5 stocks that cleared this dual screener share one defining trait. They've built businesses strong enough to generate consistent cash flow without depending on price momentum to look good. GWW leads on raw fundamental strength. COST leads on volatility floor. LLY defies the usual growth-equals-risk trade-off. ATO is the utility that earns its ranking on merit, not just sector convention. CAT is the cyclical that keeps its fundamentals intact across the full economic cycle.
In a year where the S&P 500 has been under pressure and market uncertainty remains elevated, that profile is the one worth screening for.
